188 related articles for article (PubMed ID: 36039656)
1. Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology.
Núñez J; de la Espriella R; Rossignol P; Voors AA; Mullens W; Metra M; Chioncel O; Januzzi JL; Mueller C; Richards AM; de Boer RA; Thum T; Arfsten H; González A; Abdelhamid M; Adamopoulos S; Anker SD; Gal TB; Biegus J; Cohen-Solal A; Böhm M; Emdin M; Jankowska EA; Gustafsson F; Hill L; Jaarsma T; Jhund PS; Lopatin Y; Lund LH; Milicic D; Moura B; Piepoli MF; Ponikowski P; Rakisheva A; Ristic A; Savarese G; Tocchetti CG; Van Linthout S; Volterrani M; Seferovic P; Rosano G; Coats AJS; Bayes-Genis A
Eur J Heart Fail; 2022 Oct; 24(10):1751-1766. PubMed ID: 36039656
[TBL] [Abstract][Full Text] [Related]
2. Bioactive adrenomedullin for assessment of venous congestion in heart failure.
Egerstedt A; Czuba T; Bronton K; Lejonberg C; Ruge T; Wessman T; Rådegran G; Schulte J; Hartmann O; Melander O; Smith JG
ESC Heart Fail; 2022 Oct; 9(5):3543-3555. PubMed ID: 35903845
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers and diagnostics in heart failure.
Gaggin HK; Januzzi JL
Biochim Biophys Acta; 2013 Dec; 1832(12):2442-50. PubMed ID: 23313577
[TBL] [Abstract][Full Text] [Related]
4. Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC).
Meijers WC; Bayes-Genis A; Mebazaa A; Bauersachs J; Cleland JGF; Coats AJS; Januzzi JL; Maisel AS; McDonald K; Mueller T; Richards AM; Seferovic P; Mueller C; de Boer RA
Eur J Heart Fail; 2021 Oct; 23(10):1610-1632. PubMed ID: 34498368
[TBL] [Abstract][Full Text] [Related]
5. Mid-regional pro-adrenomedullin and ST2 in heart failure: Contributions to diagnosis and prognosis.
Lopes D; Menezes Falcão L
Rev Port Cardiol; 2017 Jun; 36(6):465-472. PubMed ID: 28606358
[TBL] [Abstract][Full Text] [Related]
6. Bio-adrenomedullin as a marker of congestion in patients with new-onset and worsening heart failure.
Ter Maaten JM; Kremer D; Demissei BG; Struck J; Bergmann A; Anker SD; Ng LL; Dickstein K; Metra M; Samani NJ; Romaine SPR; Cleland J; Girerd N; Lang CC; van Veldhuisen DJ; Voors AA
Eur J Heart Fail; 2019 Jun; 21(6):732-743. PubMed ID: 30843353
[TBL] [Abstract][Full Text] [Related]
7. Adrenomedullin peptides and precursor levels in relation to haemodynamics and prognosis after heart transplantation.
Ahmed A; Kania K; Abdul Rahim H; Ahmed S; Rådegran G
ESC Heart Fail; 2023 Aug; 10(4):2427-2437. PubMed ID: 37246315
[TBL] [Abstract][Full Text] [Related]
8. Mid-regional pro-adrenomedullin in acute heart failure: a better biomarker or just another biomarker?
Potocki M; Ziller R; Mueller C
Curr Heart Fail Rep; 2012 Sep; 9(3):244-51. PubMed ID: 22733501
[TBL] [Abstract][Full Text] [Related]
9. Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society.
Tsutsui H; Albert NM; Coats AJS; Anker SD; Bayes-Genis A; Butler J; Chioncel O; Defilippi CR; Drazner MH; Felker GM; Filippatos G; Fiuzat M; Ide T; Januzzi JL; Kinugawa K; Kuwahara K; Matsue Y; Mentz RJ; Metra M; Pandey A; Rosano G; Saito Y; Sakata Y; Sato N; Seferovic PM; Teerlink J; Yamamoto K; Yoshimura M
J Card Fail; 2023 May; 29(5):787-804. PubMed ID: 37117140
[TBL] [Abstract][Full Text] [Related]
10. Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society.
Tsutsui H; Albert NM; Coats AJS; Anker SD; Bayes-Genis A; Butler J; Chioncel O; Defilippi CR; Drazner MH; Felker GM; Filippatos G; Fiuzat M; Ide T; Januzzi JL; Kinugawa K; Kuwahara K; Matsue Y; Mentz RJ; Metra M; Pandey A; Rosano G; Saito Y; Sakata Y; Sato N; Seferovic PM; Teerlink J; Yamamoto K; Yoshimura M
Eur J Heart Fail; 2023 May; 25(5):616-631. PubMed ID: 37098791
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for the diagnosis and management of heart failure.
Castiglione V; Aimo A; Vergaro G; Saccaro L; Passino C; Emdin M
Heart Fail Rev; 2022 Mar; 27(2):625-643. PubMed ID: 33852110
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of different biomarkers for cardiovascular death in unselected older patients in the emergency department.
Bahrmann P; Christ M; Hofner B; Bahrmann A; Achenbach S; Sieber CC; Bertsch T
Eur Heart J Acute Cardiovasc Care; 2016 Dec; 5(8):568-578. PubMed ID: 26483565
[TBL] [Abstract][Full Text] [Related]
13. Mid-regional pro-adrenomedullin in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study.
Pervez MO; Lyngbakken MN; Myhre PL; Brynildsen J; Langsjøen EC; Høiseth AD; Christensen G; Omland T; Røsjø H
Clin Biochem; 2017 May; 50(7-8):394-400. PubMed ID: 28065681
[TBL] [Abstract][Full Text] [Related]
14. Subclinical Myocardial Injury and the Phenotype of Clinical Congestion in Patients With Heart Failure and Reduced Left Ventricular Ejection Fraction.
Thibodeau JT; Pham DD; Kelly SA; Ayers CR; Garg S; Grodin JL; Drazner MH
J Card Fail; 2022 Mar; 28(3):422-430. PubMed ID: 34534666
[TBL] [Abstract][Full Text] [Related]
15. Prognostic potential of midregional pro-adrenomedullin following decompensation for systolic heart failure: comparison with cardiac natriuretic peptides.
Morbach C; Marx A; Kaspar M; Güder G; Brenner S; Feldmann C; Störk S; Vollert JO; Ertl G; Angermann CE;
Eur J Heart Fail; 2017 Sep; 19(9):1166-1175. PubMed ID: 28516504
[TBL] [Abstract][Full Text] [Related]
16. Uncoupling between intravascular and distending pressures leads to underestimation of circulatory congestion in obesity.
Obokata M; Reddy YNV; Melenovsky V; Sorimachi H; Jarolim P; Borlaug BA
Eur J Heart Fail; 2022 Feb; 24(2):353-361. PubMed ID: 34755429
[TBL] [Abstract][Full Text] [Related]
17. Bioactive adrenomedullin a prognostic biomarker in patients with mild to moderate dyspnea at the emergency department: an observational study.
Bronton K; Wessman T; Gränsbo K; Schulte J; Hartmann O; Melander O
Intern Emerg Med; 2022 Mar; 17(2):541-550. PubMed ID: 34173962
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular biomarkers predict post-discharge re-hospitalization risk and mortality among Swedish heart failure patients.
Molvin J; Jujic A; Bachus E; Gallo W; Tasevska-Dinevska G; Holm H; Melander O; Fedorowski A; Magnusson M
ESC Heart Fail; 2019 Oct; 6(5):992-999. PubMed ID: 31339668
[TBL] [Abstract][Full Text] [Related]
19. An update on the use and discovery of prognostic biomarkers in acute decompensated heart failure.
Darden D; Nishimura M; Sharim J; Maisel A
Expert Rev Mol Diagn; 2019 Nov; 19(11):1019-1029. PubMed ID: 31539485
[No Abstract] [Full Text] [Related]
20. Novel heart failure biomarkers: why do we fail to exploit their potential?
Piek A; Du W; de Boer RA; Silljé HHW
Crit Rev Clin Lab Sci; 2018 Jun; 55(4):246-263. PubMed ID: 29663841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
